Your shopping cart is currently empty

Glucosylsphingosine (Lyso-Gb1) is a naturally occurring glycosyl ceramide, a metabolite of GBA (acid β-glucosidase), involved in cellular recognition, signaling, and intercellular interactions.Glucopsychosine accumulates in certain neurodegenerative diseases (e.g., Gaucher disease), disrupts lysosomal function through activation of mammalian target of rapamycin complex 1 (mTORC1), and is a noncompetitive inhibitor of glucocerebrosidase.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $495 | 35 days | 35 days |
| Description | Glucosylsphingosine (Lyso-Gb1) is a naturally occurring glycosyl ceramide, a metabolite of GBA (acid β-glucosidase), involved in cellular recognition, signaling, and intercellular interactions.Glucopsychosine accumulates in certain neurodegenerative diseases (e.g., Gaucher disease), disrupts lysosomal function through activation of mammalian target of rapamycin complex 1 (mTORC1), and is a noncompetitive inhibitor of glucocerebrosidase. |
| In vitro | Methods: MCF7 cells were treated with glucosylsphingosine (20-45 μM, 48 hours), and cell death was determined by PI and Hoechst-33342 staining. Results: Glucosylsphingosine killed MCF7 cells independently of apoptosis, ferroptosis, and necroptosis, and induced cell death in a dose-dependent manner, with an LC50 of 33 μM.[4] |
| In vivo | Methods: Adult male C57BL/6JRj mice were treated with glucosylsphingosine (10 mg/kg, subcutaneous injection, daily, for 12 consecutive weeks) and the inflammatory changes in the mice were observed. Results: Glucosylsphingosine accumulated in peripheral tissues and induced hematological symptoms in mice, such as decreased hemoglobin and hematocrit, increased spleen weight, and mild inflammatory tissue reactions, indicating that it induced visceral inflammatory reactions in mice. [6] |
| Synonyms | Lyso-Gb1, Glucosyl-C18-sphingosine, Glucopsychosine, 1-β-D-Glucosylsphingosine |
| Molecular Weight | 461.63 |
| Formula | C24H47NO7 |
| Cas No. | 52050-17-6 |
| Smiles | O(C[C@@H]([C@@H](/C=C/CCCCCCCCCCCCC)O)N)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O |
| Storage | keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 100 mg/mL (216.62 mM), Sonication is recommended. DMSO: 80 mg/mL (173.3 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (7.15 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO/H2O
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.